RxDoctor Payments Data

Soledad Reyes

Family · Madera, CANPI 1003431172

Payments from drug & device makers

$6,793in general payments, 2019–2025

Across 88 payments — averaging $77.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Incyte Corporation$597
  • AbbVie$506
  • Amgen$497
  • Intercept Pharmaceuticals, Inc.$351
  • Ardelyx, Inc.$273
  • plus $3K from 27 others

What the payments were for

  • Food & beverage$6,781100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,793 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$40,395
JardianceEmpagliflozin34$36,927
RybelsusSemaglutide12$25,485
JanuviaSitagliptin Phosphate11$14,312
VascepaIcosapent Ethyl19$14,263
EliquisApixaban14$14,163
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog31$13,526
FarxigaDapagliflozin Propanediol11$6,931
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,276
Atorvastatin Calcium244$2,159
Gabapentin51$1,033
Albuterol Sulfate HfaAlbuterol Sulfate25$883
Metformin Hcl110$856
Omeprazole69$825
Lisinopril115$710

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,335$65,88052 claims
Boehringer IngelheimJardiance$100$36,92734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.

Other family in Madera

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →